The DOI matches its Crossref record; 90 of the 90 references it cites were found in a registry or an index.
Recent advances in tumor-targeting anticancer drug conjugates
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Continuous cultures of fused cells secreting antibody of predefined specificity
KÖHLER, G., & MILSTEIN, C. (1975) · Nature · doi:10.1038/256495a0 · Cited by 17,229
Block copolymer micelles for drug delivery: design, characterization and biological significance
Kataoka, K., Harada, A., & Nagasaki, Y. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00124-1 · Cited by 3,506
CD44: From adhesion molecules to signalling regulators
Ponta, H., Sherman, L., & Herrlich, P. A. (2003) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1004 · Cited by 2,386
Bombesin-like peptides can function as autocrine growth factors in human small-cell lung cancer
Cuttitta, F., Carney, D. N., Mulshine, J., Moody, T. W., Fedorko, J., Fischler, A., & Minna, J. D. (1985) · Nature · doi:10.1038/316823a0 · Cited by 1,349
SMS 201–995: A very potent and selective octapeptide analogue of somatostatin with prolonged action
Bauer, W., Briner, U., Doepfner, W., Haller, R., Huguenin, R., Marbach, P., Petcher, T. J., & Pless, J. (1982) · Life Sciences · doi:10.1016/0024-3205(82)90087-x · Cited by 1,331
Effects of Drug Loading on the Antitumor Activity of a Monoclonal Antibody Drug Conjugate
Hamblett, K. J., Senter, P. D., Chace, D. F., Sun, M. M. C., Lenox, J., Cerveny, C. G., Kissler, K. M., Bernhardt, S. X., Kopcha, A. K., Zabinski, R. F., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0789 · Cited by 1,247
Development of potent monoclonal antibody auristatin conjugates for cancer therapy
Doronina, S. O., Toki, B. E., Torgov, M. Y., Mendelsohn, B. A., Cerveny, C. G., Chace, D. F., DeBlanc, R. L., Gearing, R. P., Bovee, T. D., Siegall, C. B., et al. (2003) · Nature Biotechnology · doi:10.1038/nbt832 · Cited by 1,206
Distribution of the folate receptor GP38 in normal and malignant cell lines and tissues.
Weitman, S. D., Lark, R. H., Coney, L. R., Fort, D. W., Frasca, V., Zurawski, V. R., & Kamen, B. A. (1992) · PubMed · Cited by 1,011
Folate-mediated delivery of macromolecular anticancer therapeutic agents
Lu, Y., & Low, P. S. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00042-x · Cited by 941
Improving the efficacy of antibody-based cancer therapies
Carter, P. (2001) · Nature Reviews Cancer · doi:10.1038/35101072 · Cited by 833
Potocytosis: Sequestration and Transport of Small Molecules by Caveolae
Anderson, R. G. W., Kamen, B. A., Rothberg, K. G., & Lacey, S. W. (1992) · Science · doi:10.1126/science.1310359 · Cited by 735
Elnakat, H. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.01.001 · Cited by 649
Polyunsaturated fatty acids (PUFA) and eicosanoids in human health and pathologies
Tapiero, H., Nguyen Ba, G., Couvreur, P., & Tew, K. D. (2002) · Biomedicine & Pharmacotherapy · doi:10.1016/s0753-3322(02)00193-2 · Cited by 635
Griffiths, Jr. (1991) · British Journal of Cancer · doi:10.1038/bjc.1991.326 · Cited by 594
Hamann, P. R., Hinman, L. M., Hollander, I., Beyer, C. F., Lindh, D., Holcomb, R., Hallett, W., Tsou, H.-R., Upeslacis, J., Shochat, D., et al. (2002) · Bioconjugate Chemistry · doi:10.1021/bc010021y · Cited by 594
Hyaluronan-binding Proteins: Tying Up the Giant
Day, A. J., & Prestwich, G. D. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.r100036200 · Cited by 567
Leamon, C. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.01.008 · Cited by 558
Dubowchik, G. M., Firestone, R. A., Padilla, L., Willner, D., Hofstead, S. J., Mosure, K., Knipe, J. O., Lasch, S. J., & Trail, P. A. (2002) · Bioconjugate Chemistry · doi:10.1021/bc025536j · Cited by 555
Maeda, H., Fang, J., Inutsuka, T., & Kitamoto, Y. (2003) · International Immunopharmacology · doi:10.1016/s1567-5769(02)00271-0 · Cited by 537
Hyaluronan-Cell Interactions in Cancer and Vascular Disease
Toole, B. P., Wight, T. N., & Tammi, M. I. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.r100039200 · Cited by 491
Goren, D., Horowitz, A. T., Tzemach, D., Tarshish, M., Zalipsky, S., & Gabizón, A. (2000) · PubMed · Cited by 468
Gabizon, A. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.01.011 · Cited by 464
Hyaluronate receptors: key players in growth, differentiation, migration and tumor progression
Sherman, L., Sleeman, J., Herrlich, P., & Ponta, H. (1994) · Current Opinion in Cell Biology · doi:10.1016/0955-0674(94)90100-7 · Cited by 432
Participation in Normal Immune Responses of a Metastasis-Inducing Splice Variant of CD44
Arch, R., Wirth, K., Hofmann, M., Ponta, H., Matzku, S., Herrlich, P., & Zöller, M. (1992) · Science · doi:10.1126/science.1496383 · Cited by 403
Cell Biology of Extracellular Matrix
Rubin, L. (1983) · Trends in Neurosciences · doi:10.1016/0166-2236(83)90123-6 · Cited by 391
Hyaluronan Binding by Cell Surface CD44
Lesley, J., Hascall, V. C., Tammi, M., & Hyman, R. (2000) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)61467-5 · Cited by 389
Kosaki, R., Watanabe, K., & Yamaguchi, Y. (1999) · PubMed · Cited by 335
Eliaz, R. E., & Szoka, F. C. (2001) · PubMed · Cited by 330
CD44H regulates tumor cell migration on hyaluronate-coated substrate.
Thomas, L., Byers, H. R., Vink, J., & Stamenkovic, I. (1992) · The Journal of cell biology · doi:10.1083/jcb.118.4.971 · Cited by 319
Synthesis and Selective Cytotoxicity of a Hyaluronic Acid−Antitumor Bioconjugate
Luo, Y., & Prestwich, G. D. (1999) · Bioconjugate Chemistry · doi:10.1021/bc9900338 · Cited by 305
Wigmore, S. J., Ross, J. A., Stuart Falconer, J., Plester, C. E., Tisdale, M. J., Carter, D. C., & Ch Fearon, K. (1996) · Nutrition · doi:10.1016/0899-9007(95)00078-x · Cited by 297
Hyaluronan receptor-directed assembly of chondrocyte pericellular matrix.
Knudson, C. B. (1993) · The Journal of cell biology · doi:10.1083/jcb.120.3.825 · Cited by 282
Internalization of hyaluronan by chondrocytes occurs via receptor-mediated endocytosis
Hua, Q., Knudson, C. B., & Knudson, W. (1993) · Journal of Cell Science · doi:10.1242/jcs.106.1.365 · Cited by 278
A Hyaluronic Acid−Taxol Antitumor Bioconjugate Targeted to Cancer Cells
Luo, Y., Ziebell, M. R., & Prestwich, G. D. (2000) · Biomacromolecules · doi:10.1021/bm000283n · Cited by 261
Contributions of Cell Metabolism and H+ Diffusion to the Acidic pH of Tumors
Schornack, P. A., & Gillies, R. J. (2003) · Neoplasia · doi:10.1016/s1476-5586(03)80005-2 · Cited by 261
Hypothalamic Hormones and Cancer
Schally, A. V., Comaru-Schally, A. M., Nagy, A., Kovacs, M., Szepeshazi, K., Plonowski, A., Varga, J. L., & Halmos, G. (2001) · Frontiers in Neuroendocrinology · doi:10.1006/frne.2001.0217 · Cited by 254
Targeted delivery of chemotherapeutics: tumor-activated prodrug therapy
Chari, R. V. J. (1998) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(97)00095-1 · Cited by 235
Hamann, P. R., Hinman, L. M., Beyer, C. F., Lindh, D., Upeslacis, J., Flowers, D. A., & Bernstein, I. (2002) · Bioconjugate Chemistry · doi:10.1021/bc0100206 · Cited by 230
Somatostatin analogs in the diagnosis and treatment of cancer
Lamberts, S. W. J., de Herder, W. W., & Hofland, L. J. (2002) · Trends in Endocrinology & Metabolism · doi:10.1016/s1043-2760(02)00667-7 · Cited by 217
Hypothalamic Hormones and Cancer
Treichel, J. A. (1982) · Science News · doi:10.2307/3966511 · Cited by 216
Inhibition of tumor growthin vivo by hyaluronan oligomers
Zeng, C., Toole, B. P., Kinney, S. D., Kuo, J.-W., & Stamenkovic, I. (1998) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19980729)77:3<396::aid-ijc15>3.0.co;2-6 · Cited by 215
Tolcher, A. W., Ochoa, L., Hammond, L. A., Patnaik, A., Edwards, T., Takimoto, C., Smith, L., de Bono, J., Schwartz, G., Mays, T., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.05.137 · Cited by 206
Omega-3 Fatty Acids to Augment Cancer Therapy
Hardman, W. E. (2002) · The Journal of Nutrition · doi:10.1093/jn/132.11.3508s · Cited by 202
Eradication of large colon tumor xenografts by targeted delivery of maytansinoids.
Liu, C., Tadayoni, B. M., Bourret, L. A., Mattocks, K. M., Derr, S. M., Widdison, W. C., Kedersha, N. L., Ariniello, P. D., Goldmacher, V. S., Lambert, J. M., et al. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.16.8618 · Cited by 196
McBride, W. H., & Bard, J. B. (1979) · The Journal of experimental medicine · doi:10.1084/jem.149.2.507 · Cited by 192
Tumor targeting by covalent conjugation of a natural fatty acid to paclitaxel.
Bradley, M. O., Webb, N. L., Anthony, F. H., Devanesan, P. D., Witman, P. A., Hemamalini, S., Chander, M. C., Baker, S. D., He, L., Horwitz, S. B., et al. (2001) · PubMed · Cited by 180
Targeted Delivery of Doxorubicin by HPMA Copolymer-Hyaluronan Bioconjugates
Luo, Y., Bernshaw, N. J., Lu, Z.-R., Kopecek, J., & Prestwich, G. D. (2002) · Pharmaceutical Research · doi:10.1023/a:1015170907274 · Cited by 173
Hyaluronan synthase 3 overexpression promotes the growth of TSU prostate cancer cells.
Liu, N., Gao, F., Han, Z. J., Xu, X., Underhill, C. B., & Zhang, L. (2001) · PubMed · Cited by 171
Kaneko, T., Willner, D., Monkovic, I., Knipe, J. O., Braslawsky, G. R., Greenfield, R. S., & Vyas, D. M. (1991) · Bioconjugate Chemistry · doi:10.1021/bc00009a001 · Cited by 163
Identification of two hyaluronan-binding domains in the hyaluronan receptor RHAMM.
Yang, B., Zhang, L., & Turley, E. A. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)52919-7 · Cited by 160
Grammatikos, S., Subbaiah, P. V., Victor, T. A., & Miller, W. M. (1994) · British Journal of Cancer · doi:10.1038/bjc.1994.283 · Cited by 156
Vaage, J., Mayhew, E. G., Lasic, D. D., & Martin, F. J. (1992) · International Journal of Cancer · doi:10.1002/ijc.2910510618 · Cited by 150
Hawkins, R. A., Sangster, K., & Arends, M. J. (1998) · The Journal of Pathology · Cited by 148
Nagy, A., Schally, A. V., Halmos, G., Armatis, P. E., Cai, R., CSERNUS, V. J., Kovács, M., Koppán, M., Szepesházi, K., & Kahán, Z. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.4.1794 · Cited by 146
Rejmanová, P., Kopec̆ek, J., Duncan, R., & Lloyd, J. B. (1985) · Biomaterials · doi:10.1016/0142-9612(85)90037-7 · Cited by 138
The Action of Pteroylglutamic Conjugates on Man
Farber, S., Cutler, E. C., Hawkins, J. W., Harrison, J., Peirce, E. C., & Lenz, G. G. (1947) · Science · doi:10.1126/science.106.2764.619 · Cited by 128
Folate‐maytansinoids: Target‐selective drugs of low molecular weight
Ladino, C. A., Chari, R. V. J., Bourret, L. A., Kedersha, N., & Goldmacher, V. S. (1997) · International Journal of Cancer · Cited by 120
CHARI, R. V. J., Jackel, K. A., Bourret, L. A., Derr, S. M., Tadayoni, B. M., Mattocks, K. M., Shah, S., Liu, C., Blättler, W. A., & Goldmacher, V. S. (1995) · PubMed · Cited by 119
Tumor-Specific Novel Taxoid−Monoclonal Antibody Conjugates
Ojima, I., Geng, X., Wu, X., Qu, C., Borella, C. P., Xie, H., Wilhelm, S. D., Leece, B. A., Bartle, L. M., Goldmacher, V. S., et al. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm025540g · Cited by 116
Self-citationTumor Specific Novel Taxoid-Monoclonal Antibody Conjugates
Wu, X., & Ojima, I. (2004) · Current Medicinal Chemistry · doi:10.2174/0929867043455963 · Cited by 115
Self-citationCoradini, D., Pellizzaro, C., Miglierini, G., Daidone, M. G., & Perbellini, A. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19990505)81:3<411::aid-ijc15>3.0.co;2-f · Cited by 114
The Urokinase Receptor as a Potential Target in Cancer Therapy
Rømer, J., Nielsen, B. S., & Ploug, M. (2004) · Current Pharmaceutical Design · doi:10.2174/1381612043383962 · Cited by 113
Synthesis and Evaluation of Taxol–Folic Acid Conjugates as Targeted Antineoplastics
Lee, J. W., Lu, J., Low, P. S., et al. (2002) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(02)00019-6 · Cited by 104
Bombesin-Like Peptides: Of Ligands and Receptors
Spindel, E. R., Giladi, E., Segerson, T. P., & Nagalla, S. R. (1993) · Elsevier eBooks · doi:10.1016/b978-0-12-571148-7.50017-8 · Cited by 102
Hattori, Y., & Maitani, Y. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.03.007 · Cited by 102
Jungwirth, A., Pinski, J., Galvan, G., Halmos, G. B., Szepesházi, K., Gai, R. Z., Groot, K., Vadillo-Buenfil, M., & Schally, A. V. (1997) · European Journal of Cancer · doi:10.1016/s0959-8049(97)00072-5 · Cited by 97
Receptor-mediated targeted drug or toxin delivery.
Říhová, B. (1998) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(97)00084-7 · Cited by 96
Green, S. J., Tarone, G., & Underhill, C. B. (1988) · Experimental Cell Research · doi:10.1016/0014-4827(88)90393-x · Cited by 92
Turley, E., Belch, A., Poppema, S., & Pilarski, L. (1993) · Blood · doi:10.1182/blood.v81.2.446.446 · Cited by 89
Hyaluronate-independent metastatic behavior of CD44 variant-expressing pancreatic carcinoma cells.
Sleeman, J. P., Arming, S., Moll, J. F., Hekele, A., Rudy, W., Sherman, L. S., Kreil, G., Ponta, H., & Herrlich, P. (1996) · PubMed · Cited by 87
Molecular Characterization of a Novel Intracellular Hyaluronan-binding Protein
Huang, L., Grammatikakis, N., Yoneda, M., Banerjee, S. D., & Toole, B. P. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002737200 · Cited by 84
Vredenburg, M., Ojima, I., Veith, J. M., Pera, P. J., Kee, K., Cabral, F., Sharma, A. B., Kanter, P. M., Greco, W. R., & Bernacki, R. J. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.16.1234 · Cited by 81
Self-citationIHOVA, B. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(03)00235-9 · Cited by 77
Roguska, M., Pedersen, J. T., Henry, A. H., Searle, S. M. J., Roja, C. M., Avery, B. J., Hoffee, M., Cook, S., Lambert, J. M., Blättler, W. A., et al. (1996) · Protein Engineering Design and Selection · doi:10.1093/protein/9.10.895 · Cited by 67
Synthesis and structure-activity relationships of new second-generation taxoids
Ojima, I., Wang, T., Miller, M. L., Lin, S., Borella, C. P., Geng, X., Pera, P. J., & Bernacki, R. J. (1999) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(99)00629-0 · Cited by 66
Self-citationProtein tailoring for food and medical uses
Feeney, R. E., & Whitaker, J. R. (1986) · M. Dekker eBooks · Cited by 64
Huang, X., Bennett, M. A., & Thorpe, P. E. (2004) · The Prostate · doi:10.1002/pros.20074 · Cited by 63
Perspectives on Anti-HER Monoclonal Antibodies
Ranson, M., & Sliwkowski, M. X. (2002) · Oncology · doi:10.1159/000066203 · Cited by 63
Miyazaki, M., Lamharzi, N., Schally, A. V., Halmos, G. B., Szepesházi, K., Groot, K., & Cai, R. Z. (1998) · European Journal of Cancer · doi:10.1016/s0959-8049(97)10123-x · Cited by 63
Li, Q., Verschraegen, C. F., Mendoza, J. T., et al. (2004) · PubMed · Cited by 59
Takeda, M., Terasawa, H., Sakakura, M., Yamaguchi, Y., Kajiwara, M., Kawashima, H., Miyasaka, M., & Shimada, I. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m308199200 · Cited by 55
Kigawa, J., Minagawa, Y., Kanamori, Y., Itamochi, H., Cheng, X., Okada, M., Oishi, T., & Terakawa, N. (1998) · Cancer · Cited by 54
Bruell, D., Stöcker, M., Hühn, M., Redding, N., Kupper, M. B., Schumacher, P., Paetz, A., Bruns, C. J., Haisma, H. J., Fischer, R., et al. (2003) · International Journal of Oncology · doi:10.3892/ijo.23.4.1179 · Cited by 53
Onda, M., Wang, Q., Guo, H.-F., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-0570 · Cited by 53
Protein Tailoring For Food and Medical Uses
Roig, M. G. (1987) · Biochemical Education · doi:10.1016/0307-4412(87)90176-2 · Cited by 42
Gillespie, A., Broadhead, T. J., Chan, S. Y. T., Owen, J., Farnsworth, A., Sopwith, M., & Coleman, R. E. (2000) · Annals of Oncology · doi:10.1023/a:1008349300781 · Cited by 41
Selective tumor sensitization to taxanes with the mAb-drug conjugate cBR96-doxorubicin
Wahl, A. F., Donaldson, K. L., Mixan, B. J., Trail, P. A., & Siegall, C. B. (2001) · International Journal of Cancer · doi:10.1002/ijc.1364 · Cited by 36
Target-selective cytotoxicity of methotrexate conjugated with monoclonal anti-MM46 antibody
Endo, N., Takeda, Y., Kishida, K., Katō, Y., Saito, M., Umemoto, N., & Hara, T. (1987) · Cancer Immunology Immunotherapy · doi:10.1007/bf00199293 · Cited by 30
A folate receptor-targeted emulsion formulation for paclitaxel.
Stevens, P. J., & Lee, R. J. (2004) · PubMed · Cited by 21
Manabe, Y., Tsubota, T., Haruta, Y., Kataoka, K., Okazaki, M., Haisa, S., Nakamura, K., & Kimura, I. (1985) · Biochemical Pharmacology · doi:10.1016/0006-2952(85)90140-6 · Cited by 20
Cited by
Liposomes: Structure, composition, types, and clinical applications
Nsairat, H., Khater, D., Sayed, U., Odeh, F., Al Bawab, A., & Alshaer, W. (2022) · Heliyon · doi:10.1016/j.heliyon.2022.e09394 · Cited by 1,561
Lipid-Based Nanoparticles as Pharmaceutical Drug Carriers: From Concepts to Clinic
Puri, A., Loomis, K., Smith, B., Lee, J.-H., Yavlovich, A., Heldman, E., & Blumenthal, R. (2009) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v26.i6.10 · Cited by 1,069
Hyaluronic acid (hyaluronan): A review
Necas, J., Bartosikova, L., Brauner, P., & Kolar, J. (2008) · Veterinární medicína · doi:10.17221/1930-vetmed · Cited by 998
Bhirde, A. A., Patel, V., Gavard, J., Zhang, G., Sousa, A. A., Masedunskas, A., Leapman, R. D., Weigert, R., Gutkind, J. S., & Rusling, J. F. (2009) · ACS Nano · doi:10.1021/nn800551s · Cited by 853
Antibody–Drug Conjugates: A Comprehensive Review
Khongorzul, P., Ling, C. J., Khan, F. U., Ihsan, A. U., & Zhang, J. (2020) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-19-0582 · Cited by 787
Metadata
- Authors
- Jaracz, S., Chen, J., Kuznetsova, L. V., & Ojima, I.
- Venue
- Bioorganic & Medicinal Chemistry
- Publisher
- Elsevier BV
- Published
- 2005-09
- Volume
- 13
- Issue
- 17
- Pages
- 5043-5054
- ISSN
- 0968-0896 (ISSN-L)
- OpenAlex
- W1978925562
- Cited by
- 490
- References
- 90
- FWCI
- 12.07
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.